Clinical Trials Browser

Phase 2 × Withdrawn × Propranolol × Clear all

NCT03323710 2019-01-09

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis